Please login to the form below

Not currently logged in
Email:
Password:

Open Health creates new role

Gavin Jones joins the agency as its director of rare disease

Gavin JonesIn order to strengthen their experience and expertise, healthcare communications and market access group Open Health has appointed Gavin Jones into its newly formed role of director of rare disease.

Jones will work in close partnership with all of the Open Health agencies, driving their existing and future partnerships with customers working in rare diseases.

He said: “Having the opportunity to fully utilise my expertise and knowledge in supporting our customers provide patients hope for the future is a fantastic opportunity [and] I’m honoured to be representing Open Health in this important investment.”

Joining the agency with twenty years’ biopharmaceutical industry experience, Jones’ expertise lies in market access, therapy launch and patient centric services.

Commenting on his appointments, Sandy Roydon, chief executive officer of Open Health, said: “We are delighted that Gavin has joined us to further strengthen our partnerships with customers in rare disease.

“Creating a unique role within our field of expertise will enable us to offer a market leading position in supporting our customers work towards greater access and uptake of their innovative and much needed treatments.”

9th March 2018

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
M&F Health

M&F Health is a full service communications agency, dedicated to the health and wellbeing sector. We are an independent amongst...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics